Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    73,800

Stocks News & Analysis

stocks

Big-four bank earnings surge but revenue growth elusive

Shares sell off after results.
stocks

This ASX supermarkets business is now underperforming its largest competitor

Competition restrains long-term margins.
stocks

Apple earnings: Let the iPhone 17 cycle rip

We raise our fair value estimate for Apple stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,917.3036.80-0.41%
CAC 408,114.840.000.00%
DAX 4024,292.38337.821.41%
Dow JONES (US)49,499.27152.87-0.31%
FTSE 10010,363.9314.89-0.14%
HKSE26,216.39439.861.71%
NASDAQ25,114.44222.130.89%
Nikkei 22559,513.12228.200.38%
NZX 50 Index12,997.0842.12-0.32%
S&P 5007,230.1221.110.29%
S&P/ASX 2008,690.3035.30-0.40%
SSE Composite Index4,112.164.650.11%

Market Movers